Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Clinical Publication

RSS  

Articles

  • Neuropeptides in Patients with Restless Legs Syndrome

    The diurnal onset of restless legs syndrome (RLS) has been replicated in a mouse model using central instillation of the main melanocortin agonist, α-MSH, which stimulates excessive locomotion and grooming in rodents as well as a state of hyperalgesia. The actions of β-endorphin (β-EDP) oppose those of α-MSH, since β-EDP promotes passivity and analgesia. In this study, these prohormones were measured in plasma and cerebrospinal fluid in patients with RLS and compared to controls. Patients with RLS had elevated levels of α-MSH and lower levels of β-EDP compared to the control group.

  • Effect of Atrial Fibrillation Catheter Ablation on Psychological Well-Being

    A randomized trial of catheter ablation vs. medical therapy for atrial fibrillation (AF) patients has shown that anxiety and depression scores are significantly reduced by catheter ablation and are associated with decreases in AF burden and improved physical symptoms.

  • Identifying Risk Factors for Young-Onset Dementia

    In this large, population-based prospective cohort study, the investigators identified 15 risk factors that have strong associations with young-onset dementia. Modifications of these risk factors might delay the onset of, or prevent the development of, young-onset dementia.

  • How Safe Is Cannabis for the Heart?

    A nationwide Danish study of new prescriptions for medical cannabis for chronic pain compared to control patients has found that the 180-day incidence of atrial fibrillation/flutter is two-fold higher, but the absolute number of arrhythmias is small.

  • Transcatheter vs. Surgical Aortic Valve Replacement After 10 Years

    A multicenter randomized trial of transcatheter compared to surgical aortic valve replacement in low-risk older adult patients with symptomatic severe aortic stenosis has shown that major clinical outcomes and prosthetic valve failure were not different at 10 years of follow-up.

  • FDA Approves Coronary Drug-Coated Balloon Specifically for In-Stent Restenosis

    This trial randomized 600 U.S. patients with restenosis of a previously placed stent 2:1 to treatment with the AGENT drug-coated balloon or with regular balloon angioplasty. Target lesion failure at one year was significantly lower with the drug-coated balloon, as were target vessel myocardial infarction and stent thrombosis.

  • Can Bariatric Surgery Control Blood Pressure Long-Term?

    A randomized trial comparing bariatric surgery to medical therapy in hypertensive obese patients has shown that bariatric surgery effectively lowers blood pressure over five years of follow-up.

  • New RNA Interference-Based Therapy for Hypertension

    A randomized, double-blind, placebo-controlled trial of a range of doses of a new ribonucleic acid (RNA) interference drug that reduces hepatic angiotensinogen levels has shown significant mean 24-hour systolic blood pressure reductions at three months after a single subcutaneous injection.

  • Gestational Diabetes Mellitus: An Update on Care

    Early detection of gestational diabetes mellitus (GDM) allows for the implementation of appropriate interventions to reduce the adverse effects of uncontrolled hyperglycemia, making GDM screening an integral part of prenatal care. However, the question of whether to adopt universal or selective (risk-based) screening for GDM has been a subject of ongoing debate and lacks a clear international consensus.

  • Is Cannabis Abuse During Pregnancy Associated with Poor Neonatal Outcomes?

    Cannabis use disorder is associated with small but significant increased risks measured in multiple neonatal outcomes.